CVS CVS Health Corp
Company Analysis
Latest News
🟢 CVS Health Corp is trading 4.3% up today on GLP-1 program expansion and BofA price target hike
• BofA Securities has raised its price target on CVS Health to $110 from $100, maintaining a Buy rating. • The upgrade follows CVS Health's announcement of...
CVS Health Eyes 20% Upside, UBS Hikes Price on Earnings Optimism
UBS Group raised its price objective for CVS Health to $115.00 from $100.00. The investment bank maintained its buy rating on the stock. The new target...
CVS Health Sued for $250 Million Over Alleged Drug Pricing Scheme
Mount Sinai Health System, Michigan Medicine, and the University of Kansas Health System filed federal lawsuits against CVS Health. The complaints accuse CVS...
CVS Health's first quarter 2026 results beat estimates with revenue up 6.2%, leading to raised full-year guidance.
CVS Health reported first quarter 2026 revenues of $100.4 billion, a 6.2% year-over-year increase, and an Adjusted EPS of $2.57. The strong performance...
CVS Health Corp Q1 2026 Earnings Preview: What Analysts Expect on May 06, 2026
For the first quarter of 2026, analysts expect CVS Health to report consensus revenue of approximately $94.37 billion and adjusted EPS of $2.21, as the stock...
CVS’s Aetna to Pay $117.7 Million Over Alleged Medicare Risk Adjustment Overcharges
CVS Health’s Aetna unit will pay $117.7 million to resolve allegations that it violated the False Claims Act. The U.S. Department of Justice claimed the...